This study aimed to verify the ability of HQT to modulate SIRT1, IL-6, IL-1β, TNF-α, and Ac-NF-κB-p65 expression, which is closely related to inflammation in NAFLD rats. The gene discussed is SIRT1; the disease is metabolic dysfunction-associated steatotic liver disease.